8-K/A XBRL

FORM 8-K/A

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: June 2, 2023
Period of Report: May 18, 2023
Accession Number: 0001104659-23-067589

View Document ↗ View on SEC.gov ↗